L, H., V, S., S, D., K, R., S, M., N, G., . . . F, H. (2024). Population pharmacokinetics of flucloxacillin as intermittent bolus infusion in patients with Staphylococcus aureus bloodstream infection. The Journal of antimicrobial chemotherapy, 79(8), 2031. https://doi.org/10.1093/jac/dkae207
Chicago Style (17th ed.) CitationL, Hermann, Schöning V, Dräger S, Rentsch K, Moser S, Gürtler N, Sendi P, Osthoff M, and Hammann F. "Population Pharmacokinetics of Flucloxacillin as Intermittent Bolus Infusion in Patients with Staphylococcus Aureus Bloodstream Infection." The Journal of Antimicrobial Chemotherapy 79, no. 8 (2024): 2031. https://doi.org/10.1093/jac/dkae207.
MLA (9th ed.) CitationL, Hermann, et al. "Population Pharmacokinetics of Flucloxacillin as Intermittent Bolus Infusion in Patients with Staphylococcus Aureus Bloodstream Infection." The Journal of Antimicrobial Chemotherapy, vol. 79, no. 8, 2024, p. 2031, https://doi.org/10.1093/jac/dkae207.